CNASOTCTranslatedAPI E

API
Identification
- Active ingredient (INN)
- TOCOPHEROL
- Internal code
- 14 H 110
- Country of Origin
- Algeria
- Pharmaceutical form
- Chewable Tablet
- Prescription List
- OTC
- Packaging
- b/20

CNASDAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
is a prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel.
Each softgel is blue in color, opaque and imprinted with “BP 321” on one side.
Size 1 Tablet Amount Per Serving % DV %DV for Pregnant or Lactating Women Vitamin C 85 mg 142% 142% Vitamin D 3 200 IU 50% 50% Vitamin E 10 IU 33% 33% Vitamin D 6 25 mg 1250% 1000% Folate 1 mg 250% 125% (L-methylfolate calcium 676 mcg (as Xolafin-B™ Percent Daily Values are based on a 2000 calorie diet ) molar equivalent to 600 mcg of Folic Acid) (folic acid, USP 400 mcg) Vitamin B 12 12 mcg 200% 150% Calcium 140 mg 14% 11% Iron (ferrous fumarate) 27 mg 150% 150% Magnesium 45 mg 11% 10% Docosahexaenoic Acid (DHA) (from omega-3 fatty acids) 300 mg Daily Value (DV) not established OTHER INGREDIENTS: bee’s wax, hydrogenated vegetable oil, lecithin, gelatin, glycerin, purified water, titanium dioxide, FD&C Blue #1, FD&C Red #3.
PNV-DHA is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Indications
is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation.
Adverse Effects
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Warnings
Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR).
Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
Contraindications
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Dosage & Administration
Before, during and/or after pregnancy, one softgel daily or as directed by a physician.
How Supplied
is supplied in child-resistant bottles of 30 softgels (NDC# 42192-321-30).
Store at 20°.
- 25°C (68° - 77°F); excursions permitted to 15°.
- 30°C (59° - 86°F).